- Hovione Loures
- α1 receptor antagonist
- Benign prostatic hyperplasia
Hovione is a world leader in regulated markets offering APIs for human applications for over 50 years.
With an unblemished regulatory track record Hovione makes available offer an unrivalled technological range to provide the API with bespoke attributes to fit your application.
With FDA and PMDA approved sites Hovione has an uncompromising commitment to quality and is a founding member of the Rx-360 consortium.
This is not to be construed as a representation of non-infringement or as an offer to sell in those countries where such would constitute an infringement of third parties’ patent rights.